The four specific aims of this proposal apply a multiplicity of strategies to elucidate the signal transduction pathways upstream of p53, and to determine which regions of the p53 molecule receive these signals. Mechanical microinjection of precisely defined DNA molecules will be used to study the cellular response to DNA damage; this will avoid complications introduced by radiation or drug treatments that activate signal response pathways unrelated to genomic injury. Recently described mutant cell lines with defects in the Ku protein that target a DNA dependent protein kinase to sites of DNA damage will be employed to assess whether it or the kinase are involved in the DNA damage or metabolite limitation responses. The potential involvement of p53 in the senescence clock will be analyzed using microinjection to introduce telomere-like molecules of different sizes and structures extrachromosomally. Alternatively rare cutting endonucleases will be used to generate similar structures de novo in chromosomes. The ability of mismatched bases to activate p53 will be analyzed by genetic strategies to render normal cells defective for mismatch repair, and microinjection to introduce mismatch substrates in vivo. Finally, structure-function relationships will be analyzed for the conserved protein kinase target sites in the N- and C-terminal regions of p53. This latter project will employ site specific recombinases to insure that each mutated p53 allele is analyzed in the same chromosomal site, and that all are expressed at equivalent and nearly wild type levels.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA061449-18
Application #
2429792
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1993-07-01
Project End
2001-05-31
Budget Start
1997-06-01
Budget End
1998-05-31
Support Year
18
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
005436803
City
La Jolla
State
CA
Country
United States
Zip Code
92037
He, Guifen; Zhang, Yi-Wei; Lee, Jun-Ho et al. (2014) AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity. Mol Cell Biol 34:148-57
Li, Yao-Cheng; Rodewald, Luo Wei; Hoppmann, Christian et al. (2014) A versatile platform to analyze low-affinity and transient protein-protein interactions in living cells in real time. Cell Rep 9:1946-1958
Wade, Mark; Li, Yao-Cheng; Wahl, Geoffrey M (2013) MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat Rev Cancer 13:83-96
Wade, M; Li, Y C; Matani, A S et al. (2012) Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells. Oncogene 31:4789-97
Lee, Jun-Ho; Jin, Yetao; He, Guifen et al. (2012) Hypoxia activates tumor suppressor p53 by inducing ATR-Chk1 kinase cascade-mediated phosphorylation and consequent 14-3-3? inactivation of MDMX protein. J Biol Chem 287:20898-903
Wang, Yunyuan V; Leblanc, Mathias; Fox, Norma et al. (2011) Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity. Genes Dev 25:1426-38
Bernal, Federico; Wade, Mark; Godes, Marina et al. (2010) A stapled p53 helix overcomes HDMX-mediated suppression of p53. Cancer Cell 18:411-22
Wade, Mark; Wang, Yunyuan V; Wahl, Geoffrey M (2010) The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol 20:299-309
Mizuno, Hideaki; Spike, Benjamin T; Wahl, Geoffrey M et al. (2010) Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. Proc Natl Acad Sci U S A 107:22745-50
Wang, Yunyuan V; Wade, Mark; Wahl, Geoffrey M (2009) Guarding the guardian: Mdmx plays important roles in setting p53 basal activity and determining biological responses in vivo. Cell Cycle 8:3443-4

Showing the most recent 10 out of 28 publications